CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
C19 steroids are converted to estrogens in a number of human tissues by the aromatase enzyme complex, which consists of aromatase cytochrome P450 (P450arom; product of the CYP19 gene) and NADPH-cytochrome P450 reductase. Aromatase activity has been previously demonstrated in endometrial tumors. In the present study, we investigated CYP19 gene expression and its regulation in endometrial tumor samples (n = 9). Using a specific method of competitive polymerase chain reaction after reverse transcription, varying levels of P450arom transcripts were detected in all endometrial adenocarcinomas (n = 8) and one mixed Müllerian tumor studied. No correlations were observed between P450arom transcript levels and histological type of the tumor, grade, myometrial invasion, stage of the disease, or patient age. We have recently demonstrated that the tissue-specific regulation of CYP19 gene transcription is in part the consequence of alternative promoter use. The use of each promoter gives rise to a P450arom transcript with a unique untranslated 5'-end. We analyzed the untranslated first exons in 5'-terminals of P450arom transcripts in endometrial adenocarcinomas using a specific reverse transcription-polymerase chain reaction/Southern hybridization method we recently developed. Our findings indicated the gonadal-type (promoter II) and one of the adipose stromal cell-type (I.3) promoters were primarily used for P450arom expression in adenocarcinomas. On the other hand, distribution of transcripts specific for I.3, I.4 (another adipose-type promoter), and promoter II in one mixed Müllerian tumor was uniform. Placental promoter (I.1)-specific P450arom transcripts were not detected in endometrial tumors. As P450arom transcripts were detected in all endometrial malignancies studied, whereas they were not demonstrable in the disease-free endometrium, activation or failure of inhibition of aromatase expression in these tumors may serve to promote neoplastic proliferation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Source of Estrogen Production in Postmenopausal Women1
GRODIN, J. M., SIITERI, P. K., & MACDONALD, P. C. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-2-207 · Cited by 959
McNATTY, K. P., MAKRIS, A., DEGRAZIA, C., RAPIN, O., & RYAN, K. J. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-5-687 · Cited by 367
Mahendroo, M. S., Mendelson, C. R., & Simpson, E. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36538-x · Cited by 304
Self-citationMeans, G. D., Kilgore, M. W., Mahendroo, M. S., Mendelson, C. R., & Simpson, E. R. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-12-2005 · Cited by 258
Self-citation
Cited by
Estrogen production and action
Nelson, L. R., & Bulun, S. E. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117432 · Cited by 834
Self-citationSimpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773
Self-citationBulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., Gurates, B., et al. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.6 · Cited by 531
“Breast cancer, endometriosis, and uterine leiomyomata are highly responsive to estrogen for growth, as evidenced by high concentrations of estrogen receptors in these tissues (Bulun et al., 1997).”
Self-citationThe Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals
Sanderson, J. T. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl051 · Cited by 517
Theories of Endometrial Carcinogenesis: A Multidisciplinary Approach
Sherman, M. E. (2000) · Modern Pathology · doi:10.1038/modpathol.3880051 · Cited by 507
Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Self-citationEndometriosis: The pathophysiology as an estrogen-dependent disease
Kitawaki, J., Kado, N., Ishihara, H., Koshiba, H., Kitaoka, Y., & Honjo, H. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00260-1 · Cited by 370
Sanderson, J. T. (2000) · Toxicological Sciences · doi:10.1093/toxsci/54.1.121 · Cited by 362
Role of nuclear progesterone receptor isoforms in uterine pathophysiology
Patel, B., Elguero, S., Thakore, S., Dahoud, W., Bedaiwy, M., & Mesiano, S. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu056 · Cited by 353
“In addition, endometrial adenocarcinomas express enzymes involved in estrogen biosynthesis (Bulun et al., 1994; Utsunomiya et al., 2001), which may further increase the local estrogenic drive.”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Case--Control Study of Endogenous Steroid Hormones and Endometrial Cancer
Potischman, N., Hoover, R. N., Brinton, L. A., Siiteri, P., Dorgan, J. F., Swanson, C. A., Berman, M. L., Mortel, R., Twiggs, L. B., Barrett, R. J., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1127 · Cited by 297
Zeitvogel, A., Baumann, R., & Starzinski-Powitz, A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63030-1 · Cited by 276
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
Zeitoun, K. M., & Bulun, S. E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00393-3 · Cited by 256
Self-citationAromatase expression and regulation in breast and endometrial cancer
Zhao, H., Zhou, L., Shangguan, A. J., & Bulun, S. E. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0310 · Cited by 216
Self-citationAdenomyosis: the pathophysiology of an oestrogen-dependent disease
Kitawaki, J. (2006) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2006.01.010 · Cited by 143
Stratakis, C. A. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.4.1348 · Cited by 115
Endometriosis and Infertility: New Concepts
Ryan, I. P., & Taylor, R. N. (1997) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199706000-00021 · Cited by 106
Aromatase excess in cancers of breast, endometrium and ovary
Bulun, S. E., Chen, D., Lu, M., Zhao, H., Cheng, Y., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., et al. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.027 · Cited by 85
“Aromatase is also overexpressed in endometrial cancer [16].”
BackgroundMethodSelf-citationSegawa, T., Shozu, M., Murakami, K., Kasai, T., Shinohara, K., Nomura, K., Ohno, S., & Inoue, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1859 · Cited by 52
Aromatase cytochrome P450 gene expression in endometrial carcinoma
Sasano, H., Kaga, K., Sato, S., Yajima, A., Nagura, H., & Harada, N. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.586 · Cited by 32
“Bulun et al. (1994c) reported that in one adenocarcinoma with high aromatase expression, exon Ic and Id were primarily used, whereas in another mixed muillerian tumour with much lower expression exons lb, Ic and id were all used to a similar extent.”
BackgroundMethod
Metadata
- Authors
- Bulun, S. E.
- Venue
- Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1994-12-01
- Volume
- 79
- Issue
- 6
- Pages
- 1831-1834
- ISSN
- 0021-972X (ISSN-L)
- OpenAlex
- W2163168485
- Cited by
- 108
- References
- 4
- Type
- conference abstract
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.